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The molecular mechanisms linking diet, obesity, and type 2 diabetes are still poorly understood. In a recent
paper, Ohtsubo et al. (2011) show that high lipid levels induce nuclear exclusion of Foxa2 andHNF1a inb cells,
leading to impaired expression and glycosylation of proteins controlling glucose-stimulated insulin
secretion.Changes in lifestyle, in particular in
feeding behavior with increased access
to calorie-rich diets, are thought to be
major causes of the current epidemic of
obesity and the consequent increased
incidence of type 2 diabetes. This form
of diabetes is characterized by insulin re-
sistance, but overt hyperglycemia devel-
ops only when insulin secretion by
pancreatic b cells can no longer counter
decreased insulin action. The insulin
secretory defect involves both an initial
decline in the capacity of b cells to secrete
insulin in response to glucose followed by
a progressive reduction in b cell mass
(Butler et al., 2003; Henquin and Rahier,
2011). An important goal of current re-
search is therefore to uncover molecular
mechanisms linking high-fat diet (HFD)
to b cell dysfunctions. Although a large
body of data has demonstrated the
negative role of lipids on b cell function
and survival (Poitout and Robertson,
2008; Sako and Grill, 1990), detailed
molecular mechanisms are still largely
lacking. In a recent report published in
Nature Medicine, Ohtsubo et al. (2011)
provide a molecular explanation for the
decrease in glucose stimulated insulin
secretion (GSIS) caused by HFD feeding.
This mechanism involves the nuclear
exclusion of two transcription factors,
Foxa2 and Hnf1a, and a consequently
reduced expression of a glycosyltransfer-
ase required to form the N-linked oligo-
saccharide side chain of Glut2, a structure
required to maintain cell surface expres-
sion of the transporter.
Glucose-stimulated insulin secretion
requires glucose uptake and metabolism
to increase the intracellular ATP-to-ADP
ratio. This leads to plasma membrane
depolarization through closure of KATP
channels and Ca2+ influx to trigger insulin
granule exocytosis. In rodent islets, Glut2is the only transporter involved in glucose
uptake, whereas in humans both Glut1
and Glut2 participate in this process. In
a study published earlier, Ohtsubo et al.
(2005) found that in mice with genetic
inactivation of the Mgat4a gene, which
encodes the N-acetylglucosaminyl trans-
ferase GnT-4a, the Glut2 N-glycan was
not properly assembled. This led to a
failure of Glut2 to interact with the plasma
membrane lectin galectin 9 (also known
as UAT, an urate transporter), causing
Glut2 internalization thereby suppressing
glucose uptake and GSIS (Figure 1).
In this study (Ohtsubo et al., 2011),
these authors explored in more detail the
link between HFD feeding and Glut2 cell-
surface expression. They showed that
HFD induces a strong reduction inMgat4a
and Slc2a2 (Glut2) gene expression.
Chromatin immunoprecipitation analysis
showed that both Foxa2 and Hnf1a bind
to these gene promoters and that knock-
down of these transcription factors sup-
press in large part Mgat4a and Slc2a2
gene expression. Importantly, they show
that both HFD feeding of mice or expo-
sure of mouse or human islets to palmitic
acid induce the nuclear exclusion of
Foxa2 and Hnf1a. This results in lower
Glut2 expression and glycosylation by
GnT-4a, reduced glucose uptake, and
suppressed GSIS. Interestingly, palmitic
acid-induced exclusion of Foxa2 and
Hnf1a could be blocked by the antioxi-
dant N-acetylcysteine, suggesting that
lipotoxicity is caused by fatty-acid oxida-
tion and reactive oxygen species produc-
tion rather than by acting through lipid-
activated G protein-coupled receptors.
Additional support for this lipid-induced
dysfunction scenario comes from rescue
experiments in which Mgat4a or Glut2
are overexpressed in mouse b cells under
the control of the insulin promoter. IsletsCell Metabolism 1from HFD-fed transgenic mice overex-
pressing Mgat4a showed preserved gly-
cosylation and normal cell-surface ex-
pression of Glut2 and preserved GSIS.
On the other hand, overexpression of
Glut2 allowed partial restoration of trans-
porter expression at the b cell surface
upon HFD feeding and preserved GSIS.
Importantly, these new data are also
extended to the study of human islets
exposed to free fatty acids. As in mouse
islets, the lipid treatment induced reduc-
tion in Mgat4a expression and abnormal
glycosylation of Glut2. Importantly, the
glycosylation of Glut1 in human was also
abnormal, leading to its reduced cell-
surface expression. Thus, these data
show two important points. First, that
reduction in the Mgat4a expression
modifies the N-glycan structure of several
cell-surface glycoproteins—and it may be
important to identify which other cell-
surface proteins, possibly also involved
in insulin secretion, have abnormal glyco-
sylation pattern. Second, that the same
pathogenic event may underlie the nega-
tive effect of HFD in mice and humans.
Another striking observation is that
HFD-induced glucose intolerance, insulin
resistance, hepatic steatosis, and body-
weight gain, were largely prevented by
b cell overexpression of Mgat4a or Glut2.
Although it is not immediately obvious
why preventing a decline in GSIS pro-
tects against hepatic steatosis and insu-
lin resistance, one frequent characteristic
of the islets with defective GSIS is an
elevated insulin secretion rate at low
extracellular glucose concentration, and
reduced stimulation upon rise in glucose
levels. In vivo, this may result in fasting
hyperinsulinemia and be associated with
impaired rhythmic insulin secretion (Mar-
cheva et al., 2010) leading to insulin resis-
tance by downregulating insulin receptor4, October 5, 2011 ª2011 Elsevier Inc. 439
Figure 1. How HFD and Lipids Decrease Glucose-Stimulated Insulin Secretion and Lead to Type 2 Diabetes
In islets from wild-type mice fed a normal chow, Foxa2 and HNF1a control the expression of Slc2a2 (Glut2) and of Mgat4a (GnT-4a, an N-acetylglucosamine
transferase). GnT-4a is required for the formation of a N-glycan structure on Glut2 (and Glut1 in human islets), a process that takes place in the secretory pathway
(blue). The N-glycan is required to anchor the Gluts at the cell surface through interaction with a lectin, galectin9 (Gal9). In HFD-fed mice or upon exposure of
mouse or human islets to palmitic acid, Foxa2 and HNF1a are excluded from the nucleus, by a mechanism that can be inhibited by the antioxidant N-acetyl-
cysteine (NAC), suggesting that reactive oxygen species (ROS), produced as a result of lipid catabolism, are involved in this process. Nuclear exclusion of
the transcription factors reduces GnT-4a and Glut2 expression, as well as the normal glycosylation of Glut2, leading to transporter internalization, reduced
cell-surface expression, and reduced GSIS. This causes glucose intolerance, insulin resistance, and hepatic steatosis. These deregulations can be prevented
by transgenic overexpression of Mgat4a and Slc2a2.
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Previewsexpression. In muscle, insulin resistance
decreases glucose uptake, and in liver it
prevents normal suppression of gluco-
neogenesis while retaining insulin-stimu-
lated lipogenesis (Shimomura et al.,
2000). Therefore, transgenic overexpres-
sion of Mgat4a and Glut2 may maintain a
normal insulin secretion pattern in HFD-
fed mice, insensitive to the nuclear exclu-
sion of Foxa2 and HNF1a.
Even though the data strongly support
a major role for a decrease in cell-surface
expression of the glucose transporters in
the insulin secretion defect, changes in
the expression of other genes controlled
by Foxa2 and HNF1a, which are key
b cell transcription factors, may also
participate in the secretion defect and440 Cell Metabolism 14, October 5, 2011 ª20the general metabolic perturbations
observed in HFD mice. Nevertheless,
this study provides a striking example of
the primary role of b cell deregulations in
impaired glucose homeostasis and how
correcting b cell function has a global
protective effect. Importantly also, this
study identifies a molecular mechanism
linking diet, obesity, and development of
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